Manufacturer record
Lifecare Formulations Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Lifecare Formulations Pvt. Ltd (Puducherry) were declared Not of Standard Quality between October 2025 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: A042502F, Hydroxychloroquine Sulphate Tablets IP 200 mg (exp May 2027). DCL,Telangana (state lab) found it not of standard quality: Dissolution test does not comply as per IP 2022. Listed in the March 2026 alert.
Records by type
3 records linked to Lifecare Formulations Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Hydroxychloroquine Sulphate Tablets IP 200 mg | Batch A042502FMfg Jun 2025 · Exp May 2027 | Dissolution test does not comply as per IP 2022.Dissolution | DCL,TelanganaState lab | Mar 2026 |
| GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE PROLONGED RELEASE TABLETS IP(2mg + 500 mg) | Batch G522501BMfg Feb 2025 · Exp Jan 2027 | Assay (for GLIMEPIRIDE)Assay | DTL, PuducherryState lab | Nov 2025 |
| Glimilive-M2 (Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP) | Batch G522501BMfg Feb 2025 · Exp Jan 2027 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.